| Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer (NCT05945290) | Mayo Clinic | 2022-07-07 |
| Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer (NCT05244434) | City of Hope Medical Center | 2022-07-03 |
| Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors (NCT04560439) | City of Hope Medical Center | 2022-06-15 |
| Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors (NCT05452681) | University of Alabama at Birmingham | 2022-06-01 |
| A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment (NCT05243056) | University of Alabama at Birmingham | 2022-06-01 |
| Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373) | M.D. Anderson Cancer Center | 2022-04-29 |
| Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer (NCT04329065) | University of Washington | 2022-04-20 |
| Breast Cancer Survivorship Biorepository (NCT05786664) | University of Southern California | 2022-04-11 |
| Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer (NCT05319873) | Jonsson Comprehensive Cancer Center | 2022-04-07 |
| Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer (NCT05177796) | M.D. Anderson Cancer Center | 2022-03-11 |
| Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain (NCT05412953) | Mayo Clinic | 2022-02-22 |
| Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer (NCT05183828) | University of Washington | 2022-01-23 |
| Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors (NCT07259304) | University of Southern California | 2021-11-24 |
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
| An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors (NCT05012176) | Ohio State University Comprehensive Cancer Center | 2021-11-01 |
| Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer (NCT05086731) | Emory University | 2021-10-22 |
| Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer (NCT04673448) | University of Washington | 2021-10-18 |
| Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel (NCT04862585) | Ohio State University Comprehensive Cancer Center | 2021-10-07 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942) | National Cancer Institute (NCI) | 2021-08-25 |
| Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661) | National Cancer Institute (NCI) | 2021-08-09 |
| Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study (NCT04754412) | M.D. Anderson Cancer Center | 2021-07-23 |
| Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer (NCT04857697) | Mayo Clinic | 2021-07-01 |
| Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors (NCT04906200) | Ohio State University Comprehensive Cancer Center | 2021-06-28 |
| Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment (NCT05928325) | M.D. Anderson Cancer Center | 2021-06-17 |
| Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment (NCT04862195) | Blue Note Therapeutics | 2021-05-15 |
| Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer (NCT05071677) | M.D. Anderson Cancer Center | 2021-05-03 |
| Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations (NCT04550494) | National Cancer Institute (NCI) | 2021-04-26 |
| Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer (NCT04705025) | Jonsson Comprehensive Cancer Center | 2021-04-08 |
| Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors (NCT04999826) | Mayo Clinic | 2021-04-01 |
| Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer (NCT04498520) | Pamela Munster | 2021-03-31 |
| T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial (NCT04457596) | Alliance for Clinical Trials in Oncology | 2021-03-02 |
| Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer (NCT04345913) | National Cancer Institute (NCI) | 2021-03-01 |
| Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions (NCT04549571) | Alliance for Clinical Trials in Oncology | 2021-02-16 |
| Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy (NCT04927559) | University of Southern California | 2020-12-18 |
| Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer (NCT04205903) | Ohio State University Comprehensive Cancer Center | 2020-12-11 |
| Nipple Aspirate Fluid in Detecting Breast Cancer (NCT03715959) | Ohio State University Comprehensive Cancer Center | 2020-12-10 |
| SHAPE Neoadjuvant Chemotherapy Response (NCT04715958) | Kibo Nam | 2020-12-07 |
| Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer (NCT05025059) | M.D. Anderson Cancer Center | 2020-12-03 |
| National Cancer Institute "Cancer Moonshot Biobank" (NCT04314401) | National Cancer Institute (NCI) | 2020-11-11 |
| Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer (NCT04205071) | Ohio State University Comprehensive Cancer Center | 2020-11-01 |
| Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer (NCT04535323) | Mayo Clinic | 2020-09-23 |
| Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer (NCT04249622) | Mayo Clinic | 2020-09-18 |
| RBX7455 Before Surgery for the Treatment of Operable Breast Cancer (NCT04139993) | Mayo Clinic | 2020-08-31 |
| Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer (NCT04693338) | Mayo Clinic | 2020-08-20 |
| Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer (NCT04517838) | Mayo Clinic | 2020-07-31 |
| Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer (NCT04090567) | M.D. Anderson Cancer Center | 2020-07-28 |
| Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients (NCT04443413) | Mayo Clinic | 2020-06-16 |
| Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand (NCT04876378) | University of California, San Francisco | 2020-05-18 |
| Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer (NCT04294225) | Mayo Clinic | 2020-04-28 |
| Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors (NCT04200482) | Fred Hutchinson Cancer Center | 2020-02-21 |
| T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer (NCT03554044) | University of California, San Francisco | 2020-02-05 |
| Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer (NCT04249167) | Mayo Clinic | 2020-01-23 |
| Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer (NCT03979508) | Mayo Clinic | 2020-01-10 |
| Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy (NCT03872388) | M.D. Anderson Cancer Center | 2019-09-23 |
| Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer (NCT03941730) | Mayo Clinic | 2019-08-28 |
| Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer (NCT04001829) | ECOG-ACRIN Cancer Research Group | 2019-08-09 |
| Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study (NCT03707574) | National Cancer Institute (NCI) | 2019-07-16 |
| Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer (NCT03207529) | M.D. Anderson Cancer Center | 2019-06-07 |
| Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer (NCT04678414) | M.D. Anderson Cancer Center | 2019-04-01 |
| Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors (NCT03751449) | Roswell Park Cancer Institute | 2019-03-25 |
| Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors (NCT04454086) | Ohio State University Comprehensive Cancer Center | 2019-03-06 |
| ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors (NCT03725436) | M.D. Anderson Cancer Center | 2019-01-24 |
| EXERCISING TOGETHER for Couples Coping With Cancer (NCT03630354) | OHSU Knight Cancer Institute | 2019-01-18 |
| Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer (NCT03786354) | Ohio State University Comprehensive Cancer Center | 2019-01-09 |
| A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer (NCT04086875) | Thomas Jefferson University | 2018-11-07 |
| PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery (NCT03218826) | National Cancer Institute (NCI) | 2018-09-24 |
| Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer (NCT03774472) | M.D. Anderson Cancer Center | 2018-08-20 |
| Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma (NCT03941756) | M.D. Anderson Cancer Center | 2018-08-14 |
| Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer (NCT03505671) | Wake Forest University Health Sciences | 2018-08-03 |
| Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer (NCT03505736) | Wake Forest University Health Sciences | 2018-06-21 |
| Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer (NCT03518242) | Fred Hutchinson Cancer Center | 2018-06-06 |
| Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors (NCT03523195) | Fred Hutchinson Cancer Center | 2018-04-18 |
| IACS-010759 in Advanced Cancers (NCT03291938) | M.D. Anderson Cancer Center | 2017-11-13 |
| TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer (NCT03179904) | Mayo Clinic | 2017-08-03 |
| Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer (NCT03132467) | M.D. Anderson Cancer Center | 2017-06-13 |
| Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer (NCT03106077) | M.D. Anderson Cancer Center | 2017-06-05 |
| Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer (NCT02918474) | M.D. Anderson Cancer Center | 2017-04-28 |
| Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer (NCT02849496) | National Cancer Institute (NCI) | 2017-03-30 |
| Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer (NCT02453620) | National Cancer Institute (NCI) | 2016-02-12 |
| Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic (NCT02115282) | National Cancer Institute (NCI) | 2014-03-29 |
| Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer (NCT01334021) | M.D. Anderson Cancer Center | 2011-05-31 |
| Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer (NCT01149083) | National Cancer Institute (NCI) | 2010-06-30 |
| Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer (NCT00507923) | M.D. Anderson Cancer Center | 2006-11-07 |